Robert More, MBA
Independent DirectoratVir Biotechnology· In proxies 2023–2025
Robert More, MBA sits on 15 public boards.
Boards1
- Vir BiotechnologyDirector · 8 yr on the boardIndependentAudit, Directors and Compensation—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Vir BiotechnologyPublic company · 3 yr
- Independent Director2023 – Present · 3 yrStock in role -52%
- Tyra Biosciences, Inc. (Chairman)Public company · 5 yr
- Director2021 – Present · 5 yrNo stock prices for these years
- Tyra Biosciences, Inc.Public company · 8 yr
- Director2018 – Present · 8 yrNo stock prices for these years
- Amplitude Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Qihan BiotechPublic company
- Director? – PresentNo stock prices for these years
- Sirenas, LLCPublic company
- Director? – PresentNo stock prices for these years
- Variant Bio, Inc.Public company
- Director? – PresentNo stock prices for these years
- eGenesis, Inc.Public company
- Director? – PresentNo stock prices for these years
- Achaogen, Inc.Public company
- Director? – PresentNo stock prices for these years
- Affinivax, Inc.Public company
- Director? – PresentNo stock prices for these years
- Carticept Medical, Inc.Public company
- Director? – PresentNo stock prices for these years
- Glaukos CorporationPublic company
- Director? – PresentNo stock prices for these years
- IntraLase Corp.Public company
- Director? – PresentNo stock prices for these years
- Neothetics Inc.Public company
- Director? – PresentNo stock prices for these years
- Sienna Biopharmaceuticals, Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?